Viewing Study NCT06539559


Ignite Creation Date: 2025-12-24 @ 2:52 PM
Ignite Modification Date: 2025-12-25 @ 1:18 PM
Study NCT ID: NCT06539559
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-08-06
First Post: 2024-07-28
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Efficacy and Resistant Mechanism of Eribulin and Bevacizumab for Advanced HER2 Negative Breast Cancer
Sponsor: Wang Jiayu
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module